Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer

BACKGROUND: Patients with hereditary diffuse gastric cancer (HDGC), a cancer predisposition syndrome associated with germline mutations of the CDH1 (E-cadherin) gene, have few effective treatment options. Despite marked differences in natural history, histopathology, and genetic profile to patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ina, Mathews-Greiner, Lesley, Li, Dandan, Abisoye-Ogunniyan, Abisola, Ray, Satyajit, Bian, Yansong, Shukla, Vivek, Zhang, Xiaohu, Guha, Raj, Thomas, Craig, Gryder, Berkley, Zacharia, Athina, Beane, Joal D., Ravichandran, Sarangan, Ferrer, Marc, Rudloff, Udo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412046/
https://www.ncbi.nlm.nih.gov/pubmed/28460635
http://dx.doi.org/10.1186/s12967-017-1197-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412046/
https://www.ncbi.nlm.nih.gov/pubmed/28460635
http://dx.doi.org/10.1186/s12967-017-1197-5

Ejemplares similares